What is the issue for NSW?
The research addresses the critical issue of thrombotic diseases in NSW, focusing on heart attacks and strokes that significantly impact the population. By developing an advanced imaging profiling platform and leveraging insights from a diverse set of blood donors, the research aims to improve diagnostics and monitoring of blood clot formation. This has direct implications for healthcare in NSW, where cardiovascular diseases are a major concern, leading to significant morbidity and mortality. The outcomes of this research could lead to more accurate and timely diagnosis, better treatment strategies, and ultimately improved patient outcomes for individuals in NSW facing thrombotic conditions.
What does the research aim to do and how?
The research aims to understand and improve how we detect and manage blood clotting issues like heart attacks and strokes in NSW. It will utilise a sophisticated imaging system to study blood samples from different people to see how clotting works and what factors affect it. This will enable better ways to diagnose and treat these conditions, which are a big problem in NSW and can cause serious health issues. The goal is to improve how doctors can identify and treat blood clotting problems, leading to better outcomes for patients across the state.
The top three key measures/indicators being used to assess the research outcomes are:
- Accuracy of diagnosis: measure how accurately the new diagnostic methods detect blood clotting issues compared to existing methods.
- Treatment effectiveness: evaluate how well the new treatment strategies improve patient outcomes and reduce complications related to blood clotting disorders.
- Healthcare impact: assess the overall impact of the research on healthcare practices, such as changes in guidelines, reduced hospitalization rates, and improved patient management.